Illumina Tops Q2 Estimates and Lifts Full-Year Outlook on Robust NovaSeq X Demand
ILMN has more than doubled off its 52-week low of $88.
Summary
Illumina reported Q2 2026 revenue of $1.16 billion, up 9.5% year-over-year, and raised its full-year revenue and earnings guidance. The beat was driven by strong NovaSeq X demand and expanding clinical sequencing applications.
Key Events · Earnings and Guidance · ILMN
-
Q2 Revenue and EPS Beat
Revenue of $1.16 billion grew 9.5% YoY, exceeding the $1.13 billion consensus. Non-GAAP diluted EPS of $1.31 beat expectations.
-
Full-Year Guidance Raised
FY2026 revenue guidance increased to $4.60-$4.64 billion (from $4.52-$4.62 billion). Non-GAAP EPS guidance raised to $5.30-$5.40 (from $5.15-$5.30).
-
NovaSeq X Demand Drives Growth
Management highlighted high demand for NovaSeq X as clinical customers expand sequencing-intensive applications, driving 8.1% ROW organic revenue growth.
-
Strong Cash Position
Cash, cash equivalents, and short-term investments totaled $1.17 billion at quarter-end, providing ample liquidity for operations and the ongoing $1.5 billion share repurchase program.
Analysis · ILMN · Industrial Applications And Services
A clean beat-and-raise quarter underscores Illumina's accelerating momentum. Revenue of $1.16 billion surpassed the $1.13 billion consensus, while adjusted EPS of $1.31 exceeded expectations. Bolstered by strong NovaSeq X demand and expanding clinical applications, management raised full-year revenue guidance to $4.60–$4.64 billion and non-GAAP EPS to $5.30–$5.40. The stock is trading near its 52-week high, reflecting market confidence in the turnaround story after a turbulent period. This report reinforces the narrative that organic growth is accelerating and margins are improving.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 35.6% of the 1819 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ILMN was trading at $197.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $31B. The 52-week trading range was $88.00 to $205.47. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.